insights_auto
Why is NVSEF up 3.12%?
Dive Deeperchevron_right
NVSEF:OTCMKTS
Novartis AG
$ 139.98
arrow_upward
+3.12%(+4.23) 1D
10-р сарын 9, 16:00:00 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVSEF...
Open
$ 146.23
High
$ 146.23
Low
$ 139.98
Mkt. cap
288.81Т
Avg. vol.
30.92 мян
Volume
581.00
52-wk high
$ 171.29
52-wk low
$ 120.00
Beta
0.40
Shares outstanding
2.03 тэрбум
No. of employees
75 мян
Open
$ 146.23
High
$ 146.23
Low
$ 139.98
Mkt. cap
288.81Т
Avg. vol.
30.92 мян
Volume
581.00
52-wk high
$ 171.29
52-wk low
$ 120.00
Beta
0.40
Shares outstanding
2.03 тэрбум
No. of employees
75 мян
News stories
From web sources and news partners
AD HOC NEWS
·
1 өдрийн өмнө
Novartis stock ends week at EUR 127.97 with EUR 128.88 high
AD HOC NEWS
·
2 өдрийн өмнө
Novartis stock trades at EUR 127.87 while volume is 21.5 percent below average
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3 мян
Founded1996 оны 3-р сарын 7
HeadquartersБазель хот, Basel City, Швейцари
SectorPharmaceutical industry
Websitenovartis.com